about
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapyProphylactic anti-infective activity of poly-[1-6]-beta-D-glucopyranosyl-[1-3]-beta-D-glucopryanose glucan in a guinea pig model of staphylococcal wound infectionGenetics of zwittermicin a production by Bacillus cereusBench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumoniaCurrent concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococciCyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteriaHIV-1 Protease Inhibitors from Inverse Design in the Substrate Envelope Exhibit Subnanomolar Binding to Drug-Resistant VariantsUse of germicides in the home and the healthcare setting: is there a relationship between germicide use and antibiotic resistance?Unique antimicrobial effects of platelet-rich plasma and its efficacy as a prophylaxis to prevent implant-associated spinal infectionTurning defense into offense: defensin mimetics as novel antibiotics targeting lipid IIAntibiotic exposure in a low-income country: screening urine samples for presence of antibiotics and antibiotic resistance in coagulase negative staphylococcal contaminantsProduction of potent antimicrobial agent by actinomycete, Streptomyces sannanensis strain SU118 isolated from phoomdi in Loktak Lake of Manipur, India.Use of local community hospital data for surveillance of antimicrobial resistance.Peptide ligands in antibacterial drug discovery: use as inhibitors in target validation and target-based screening.Genomics and antimicrobial drug discovery.Identification of clinically relevant enterococcus species by direct sequencing of groES and spacer region.In vivo activity and pharmacokinetic evaluation of a novel long-acting carbapenem antibiotic, MK-826 (L-749,345).Ascorbate recycling in human neutrophils: induction by bacteria.Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffoldsRisk factors for antibiotic-resistant Escherichia coli carriage in young children in Peru: community-based cross-sectional prevalence studyRandomised controlled trial of CRP rapid test as a guide to treatment of respiratory infections in general practice.Outbreak of nosocomial infections due to extended-spectrum beta-lactamase-producing strains of enteric group 137, a new member of the family Enterobacteriaceae closely related to Citrobacter farmeri and Citrobacter amalonaticusAbility of laboratories to detect emerging antimicrobial resistance: proficiency testing and quality control results from the World Health Organization's external quality assurance system for antimicrobial susceptibility testing.Vancomycin-resistant enterococci.Two pharmacodynamic models for assessing the efficacy of amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniaeEfficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniaePharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin.Efficacy of an evernimicin (SCH27899) in vitro and in an animal model of Lyme disease.Identification of aerobically and anaerobically induced genes in Enterococcus faecalis by random arbitrarily primed PCRModulation of endotoxin- and enterotoxin-induced cytokine release by in vivo treatment with beta-(1,6)-branched beta-(1,3)-glucan.Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.A review of clinical trials with fluoroquinolones with an emphasis on new agents.Escherichia coli bacteriocins: antimicrobial efficacy and prevalence among isolates from patients with bacteraemia.Antimicrobial resistance in Canada.The global challenge of antimicrobial resistance: insights from economic analysis.History of antibiotics. From salvarsan to cephalosporins.Vancomycin-resistant enterococci: mechanisms and clinical observations.Modified Double Disc Synergy Test to Detect ESBL Production in Urinary Isolates of Escherichia coli and Klebsiella pneumoniae.Bacterial resistance to vancomycin: overproduction, purification, and characterization of VanC2 from Enterococcus casseliflavus as a D-Ala-D-Ser ligase.The effect of an antimicrobial formulary change on hospital resistance patterns.
P2860
Q24519008-D3341487-2164-4592-8606-B2450CE01EB8Q24519010-CEE6B4EE-4E13-49B7-A66F-5AD399178AA3Q24630084-6F4DD245-86C4-4D5A-9AB8-95B14262E47CQ24811492-DC484314-9095-45AE-BA66-2E22E6F04962Q26853465-F56138E1-B5CC-47B2-8BB5-369517815D02Q26863225-660F82C4-4B23-449E-B739-7E5009091BA6Q27650325-5BF1E86C-AA7B-4CF5-989A-E7013A954B81Q28265803-9AB3A088-1102-450C-991E-A24F537A68F1Q28388676-93131249-47FF-4959-B8F8-BC518371AEE7Q28534946-15414AAB-698E-4923-8C40-58ED55B0FC15Q28542403-D028C8CD-3C17-49F4-A28D-92E60A75E9CFQ30390187-E5EE2AAA-28F1-41D2-BDE1-387458C8CD3AQ31034124-55923E31-2FE4-41D7-90C7-4156A6C2277EQ31108870-B8317B80-3787-4C24-A84D-45B7B546D9DAQ33537162-DADA53BE-983A-41C7-AE23-149D31A7F4E5Q33592256-7FCC9C72-0016-4C8E-8B33-819B445055C1Q33694847-E731AF18-6493-4CFC-AC66-4F784E5A7E12Q33729472-E067DE42-8AC3-4897-B121-5622315E6959Q33742858-7C65485E-B8D1-4E72-906C-F15F067CE14DQ33817614-D1BDEEFD-B0F6-4437-B0D8-3EE0B715CD6DQ33918697-C910BA72-F88D-46EA-8DB0-44E8151EDC1BQ33970165-B505BF8A-F53A-47D0-849A-5E512AF8B5E7Q33970955-95F17CC3-D1EB-4FEA-8B57-4C76BB1DEF5FQ33975592-8DC9A622-A3EC-4039-85BA-D051E327D6CFQ33975832-237ECFE9-95D3-4715-B3B7-B354E4F8B1F1Q33975838-35E3080C-40A1-4FF3-B631-5A9C37189A5CQ33979388-98D536E2-E391-4E82-9D35-163B8685E6CFQ33981730-31C203E6-2F6B-49D7-B946-BB62DAB77361Q33984589-61AD00E8-B627-4913-ACE7-24BF8EDD503BQ33999994-E92E3ECB-1EEF-4509-86DC-A74CDF2C2B23Q34052619-8C663C6A-BD6C-4FE9-9595-C776D57BE873Q34074724-93B6FF6D-351F-41B5-AD7D-724B6D24B3CBQ34113611-C69D0204-A556-4011-92C4-2459226F9B49Q34133853-6D49770D-1881-455A-939E-7D50796A46D2Q34196900-EB86CDBC-D324-45A2-A4DF-270937A9C017Q34262986-2C749ECE-34E5-497C-80D1-79846E0CFFD7Q34289227-5F38A393-BEA9-418B-88EA-73B97AC9B59BQ34336140-D1B02D01-E838-4C27-BB9A-FC388FCCDD41Q34438814-03FEABC8-3DC8-4FF0-A48C-07B5724EEA87Q34496123-D20DC8AB-36DA-4D5D-B4D0-846B06E06728
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Antimicrobial-drug resistance.
@en
type
label
Antimicrobial-drug resistance.
@en
prefLabel
Antimicrobial-drug resistance.
@en
P1476
Antimicrobial-drug resistance.
@en
P2093
Moellering RC Jr
P304
P356
10.1056/NEJM199611073351907
P407
P577
1996-11-01T00:00:00Z